Cargando…

Novel chemical starting points for drug discovery in leishmaniasis and Chagas disease

Visceral leishmaniasis (VL) and Chagas disease (CD) are caused by kinetoplastid parasites that affect millions of people worldwide and impart a heavy burden against human health. Due to the partial efficacy and toxicity-related limitations of the existing treatments, there is an urgent need to devel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roquero, Irene, Cantizani, Juan, Cotillo, Ignacio, Manzano, M. Pilar, Kessler, Albane, Martín, J. Julio, McNamara, Case W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545338/ https://www.ncbi.nlm.nih.gov/pubmed/31158574 http://dx.doi.org/10.1016/j.ijpddr.2019.05.002

Ejemplares similares

Rate-of-Kill (RoK) assays to triage large compound sets for Chagas disease drug discovery: Application to GSK Chagas Box
por: Cantizani, Juan, et al.
Publicado: (2021)

New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open Resource
por: Peña, Imanol, et al.
Publicado: (2015)

Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas’ disease drug discovery
por: MacLean, Lorna M., et al.
Publicado: (2018)

DIY Virtual Chemical Libraries - Novel Starting Points for Drug Discovery
por: Takács, Gergely, et al.
Publicado: (2023)

Importance of secondary screening with clinical isolates for anti-leishmania drug discovery
por: Hefnawy, Aya, et al.
Publicado: (2018)

Automated High-Content Assay for Compounds Selectively Toxic to Trypanosoma cruzi in a Myoblastic Cell Line
por: Alonso-Padilla, Julio, et al.
Publicado: (2015)

Probing the Open Global Health Chemical Diversity Library for Multistage-Active Starting Points for Next-Generation Antimalarials
por: Abraham, Matthew, et al.
Publicado: (2020)

Editorial: Discovery and Development of Drugs for Neglected Diseases: Chagas Disease, Human African Trypanosomiasis, and Leishmaniasis
por: Rivera, Gildardo, et al.
Publicado: (2021)

Advances in Antiwolbachial Drug Discovery for Treatment of Parasitic Filarial Worm Infections
por: Bakowski, Malina A., et al.
Publicado: (2019)

Utilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas Disease
por: Khare, Shilpi, et al.
Publicado: (2015)

A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery
por: Almela, Maria Jesus, et al.
Publicado: (2015)

Agrochemicals against Malaria, Sleeping Sickness, Leishmaniasis and Chagas Disease
por: Witschel, Matthias, et al.
Publicado: (2012)

Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
por: Khare, Shilpi, et al.
Publicado: (2016)

Asteraceae Plants as Sources of Compounds Against Leishmaniasis and Chagas Disease
por: Moraes Neto, Roberval Nascimento, et al.
Publicado: (2019)

An Overview on the Therapeutics of Neglected Infectious Diseases—Leishmaniasis and Chagas Diseases
por: J, Brindha, et al.
Publicado: (2021)

A note on the the discovery of Chagas' disease
por: de Avila-Pires, Fernando Dias
Publicado: (2022)

Renal dysfunction in Leishmaniasis and Chagas disease coinfection: a case report
por: de Alcântara, Cid Carlos Soares, et al.
Publicado: (2018)

Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases?
por: Scariot, Debora B., et al.
Publicado: (2022)

The Q(i) Site of Cytochrome b is a Promiscuous Drug Target in Trypanosoma cruzi and Leishmania donovani
por: Wall, Richard J., et al.
Publicado: (2020)

Chemical Starting Matter for HNF4α Ligand Discovery and Chemogenomics
por: Meijer, Isabelle, et al.
Publicado: (2020)

Application of a phenotypic drug discovery strategy to identify biological and chemical starting points for inhibition of TSLP production in lung epithelial cells
por: Orellana, Adelina, et al.
Publicado: (2018)

Biosynthesis of Galactofuranose in Kinetoplastids: Novel Therapeutic Targets for Treating Leishmaniasis and Chagas' Disease
por: Oppenheimer, Michelle, et al.
Publicado: (2011)

Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy
por: Santi, Ana Maria Murta, et al.
Publicado: (2022)

Carlos Chagas Discoveries as a Drop Back to Scientific Construction of Chronic Chagas Heart Disease
por: Bestetti, Reinaldo B., et al.
Publicado: (2016)

Screening of the Pathogen Box reveals new starting points for anti-trypanosomal drug discovery
por: Veale, Clinton G. L., et al.
Publicado: (2018)

Concurrent Chagas’ disease and borderline disseminated cutaneous leishmaniasis: The role of amiodarone as an antitrypanosomatidae drug
por: Paniz-Mondolfi, Alberto E, et al.
Publicado: (2008)

Parasite Prolyl Oligopeptidases and the Challenge of Designing Chemotherapeuticals for Chagas Disease, Leishmaniasis and African Trypanosomiasis
por: Bastos, I.M.D, et al.
Publicado: (2013)

Therapeutic Interventions for Countering Leishmaniasis and Chagas’s Disease: From Traditional Sources to Nanotechnological Systems
por: Souto, Eliana B., et al.
Publicado: (2019)

The Centennial of the Discovery of Chagas Disease: Facing the Current Challenges
por: Lannes-Vieira, Joseli, et al.
Publicado: (2010)

Discovery and Genetic Validation of Chemotherapeutic Targets for Chagas' Disease
por: Osorio-Méndez, Juan Felipe, et al.
Publicado: (2019)

Advances in preclinical approaches to Chagas disease drug discovery
por: Villalta, Fernando, et al.
Publicado: (2019)

FC-TRIPLEX Chagas/Leish IgG1: A Multiplexed Flow Cytometry Method for Differential Serological Diagnosis of Chagas Disease and Leishmaniasis
por: Teixeira-Carvalho, Andréa, et al.
Publicado: (2015)

High-Content Phenotypic Profiling in Esophageal Adenocarcinoma Identifies Selectively Active Pharmacological Classes of Drugs for Repurposing and Chemical Starting Points for Novel Drug Discovery
por: Hughes, Rebecca E., et al.
Publicado: (2020)

Chemoinformatics Strategies for Leishmaniasis Drug Discovery
por: Ferreira, Leonardo L. G., et al.
Publicado: (2018)

Natural compounds based chemotherapeutic against Chagas disease and leishmaniasis: mitochondrion as a strategic target
por: Lazarin-Bidóia, Danielle, et al.
Publicado: (2022)

Chagas Disease: From Discovery to a Worldwide Health Problem
por: Lidani, Kárita Cláudia Freitas, et al.
Publicado: (2019)

Chagas Disease: Perspectives on the Past and Present and Challenges in Drug Discovery
por: Mansoldo, Felipe Raposo Passos, et al.
Publicado: (2020)

Telemedicine in Italy, the starting point
por: Parretti, Chiara, et al.
Publicado: (2022)

Visceral leishmaniasis: Experimental models for drug discovery
por: Gupta, Suman, et al.
Publicado: (2011)

Evaluation of Molecular Methods to Identify Chagas Disease and Leishmaniasis in Blood Donation Candidates in Two Brazilian Centers
por: Ferreira, Juliana de Jesus Guimarães, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e3pvgd7hjkk03seo9tltog2mck